Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.95B | 1.82B | 1.86B | 1.81B | 1.86B | Gross Profit |
800.30M | 754.10M | 884.30M | 874.30M | 908.40M | EBIT |
480.20M | 441.40M | 641.50M | 641.00M | 688.00M | EBITDA |
992.70M | 1.18B | 1.19B | 1.16B | 1.06B | Net Income Common Stockholders |
126.90M | 204.90M | -56.80M | 453.40M | 106.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.40B | 340.40M | 240.90M | 744.10M | 528.10M | Total Assets |
15.65B | 14.53B | 14.44B | 14.18B | 14.04B | Total Debt |
10.00B | 8.44B | 7.98B | 8.45B | 8.36B | Net Debt |
8.60B | 8.43B | 7.74B | 7.71B | 7.83B | Total Liabilities |
13.60B | 12.02B | 11.48B | 11.15B | 11.08B | Stockholders Equity |
2.06B | 2.51B | 2.96B | 3.03B | 2.96B |
Cash Flow | Free Cash Flow | |||
-19.00M | 93.50M | 305.90M | 221.80M | 135.20M | Operating Cash Flow |
745.10M | 787.50M | 934.40M | 865.80M | 815.20M | Investing Cash Flow |
-731.40M | -593.40M | -639.70M | -555.70M | -598.80M | Financing Cash Flow |
1.04B | -85.00M | -809.70M | -89.70M | -27.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £7.06B | 5.55 | 32.10% | 2.92% | -24.74% | -63.34% | |
71 Outperform | £7.76B | 33.26 | 17.17% | 4.59% | 5.38% | 86.34% | |
71 Outperform | £17.08B | 8.79 | 21.94% | 3.94% | -13.09% | 231.40% | |
67 Neutral | £49.56B | 23.45 | 5.28% | 5.43% | -6.68% | -77.57% | |
65 Neutral | $11.90B | 15.77 | 6.20% | 4.52% | 5.53% | -8.93% | |
64 Neutral | £7.28B | 64.28 | 5.50% | 4.73% | 8.61% | ― | |
53 Neutral | £2.16B | ― | -4.09% | 7.73% | 20.25% | -128.71% |